Oral drug therapy for female sexual dysfunction

International Journal of Impotence Research

Volumn 12, Issue , 2000, Pages S56-S57

  Padma Nathan, H ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; ARGININE; PHOSPHODIESTERASE INHIBITOR; SILDENAFIL; VASOACTIVE AGENT; YOHIMBINE;

CLINICAL TRIAL; CONFERENCE PAPER; FEMALE; FEMALE SEXUAL DYSFUNCTION; HEADACHE; HOT FLUSH; HUMAN; PATIENT SATISFACTION; PRIORITY JOURNAL; RHINITIS; SEXUAL AROUSAL; SEXUAL FUNCTION;

ADULT; FEMALE; HUMANS; PIPERAZINES; SEROTONIN UPTAKE INHIBITORS; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 0034524987     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/sj.ijir.3900608     Document Type: Article

References (4)

1. Basson R et al. Report of the international consensus conference on female sexual dysfunction: definitions and classifications. J Urol 2000; 163: 888-893.
2. Rosen et al. The female sexual function index: a multidimensional sell-report instrument for the assessment of female sexual function. J Marial and Sex Ther 2000; 26: 191-208.
3. Besson R. The female sexual response: a different model. J Marial and Sex Ther 2000; 26: 51-65.
4. Besson R and Mclnnes R. Efficacy and safety of sildenafil in estrogenized women with sexual dysfunction associated with female sexual arousal disorder. Ob Gyn 2000; 95: 54S.